As of 2025-09-17, the Relative Valuation of Poseida Therapeutics, Inc. (PSTX) is (5.38) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.50 USD, the upside of Poseida Therapeutics, Inc. based on Relative Valuation is -156.6%.
The range of the Relative Valuation is (4.24) - (7.09) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.4x - 11.4x | 7.9x |
| Forward P/E multiples | 6.8x - 11.9x | 9.4x |
| Fair Price | (4.24) - (7.09) | (5.38) |
| Upside | -144.6% - -174.7% | -156.6% |
| Date | P/E |